About Hospital Universitari Vall d'Hebron; Servicio de Hepatologia
Clinical Trials at Hospital Universitari Vall d'Hebron; Servicio de Hepatologia
During the past decade, Hospital Universitari Vall d'Hebron; Servicio de Hepatologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Vall d'Hebron; Servicio de Hepatologia"
#1 collaborator was "A2F Associates Limited" with 2 trials as a collaborator, "Alpha Bioresearch S.L." with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Azienda Ospedaliera di Padova" with 2 trials as a collaborator and "Hospital Universitari Vall d'Hebron Research Institute" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Hospital Universitari Vall d'Hebron; Servicio de Hepatologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitari Vall d'Hebron; Servicio de Hepatologia" are
"Carcinoma, Hepatocellular" (2 trials), "Liver Cirrhosis" (1 trials), "Non-Alcoholic Steatohepatitis" (1 trials) and "Unresectable Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Hospital Universitari Vall d'Hebron; Servicio de Hepatologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitari Vall d'Hebron; Servicio de Hepatologia
Most popular intervention types in "Hospital Universitari Vall d'Hebron; Servicio de Hepatologia" are "Drug" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Placebo" (2 trials), "4g Placebo" (1 trials), "4g Yaq-001" (1 trials) and "8g Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitari Vall d'Hebron; Servicio de Hepatologia
The vast majority of trials in "Hospital Universitari Vall d'Hebron; Servicio de Hepatologia" are
5 trials for "All" genders.
Clinical Trials Status at Hospital Universitari Vall d'Hebron; Servicio de Hepatologia
Currently, there are NaN active trials in "Hospital Universitari Vall d'Hebron; Servicio de Hepatologia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hospital Universitari Vall d'Hebron; Servicio de Hepatologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitari Vall d'Hebron; Servicio de Hepatologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".